Search research articles
Contact Us
Filters
Showing results (1351-1360 of 1,387) with videos related to
Page
of 139
Sort By:
Annals of Hematology
|
December 7, 2017
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens
L E M Oosten, M E D Chamuleau, F W Thielen, et al.
Clinical and Translational Radiation Oncology
|
May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2021
Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial Analysis
Stéphane Giorgiutti, Yannick Dieudonne, Olivier Hinschberger, et al.
Journal of ISAKOS : Joint Disorders & Orthopaedic Sports Medicine
|
August 23, 2022
Return to sport soccer after anterior cruciate ligament reconstruction: ISAKOS consensus
David Figueroa, Guillermo Arce, João Espregueira-Mendes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2017
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
S Tanadini-Lang, J Rieber, A R Filippi, et al.
Leukemia
|
May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
John M M Raemaekers, Marc P E André, Massimo Federico, et al.
The New England Journal of Medicine
|
December 25, 2015
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma
Michael Schaapveld, Berthe M P Aleman, Anna M van Eggermond, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 2, 2023
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
E Gkika, D Kostyszyn, T Fechter, et al.
Journal of the National Cancer Institute
|
December 22, 2020
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone de Vries, Michael Schaapveld, Cécile P M Janus, et al.
Page
of 139
Search research articles
Search
Showing results (1351-1360 of 1,387) with videos related to
Sort By:
Page
of 139
Annals of Hematology
|
December 7, 2017
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens
L E M Oosten, M E D Chamuleau, F W Thielen, et al.
Clinical and Translational Radiation Oncology
|
May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2021
Prevalence of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture-Recapture and Geospatial Analysis
Stéphane Giorgiutti, Yannick Dieudonne, Olivier Hinschberger, et al.
Journal of ISAKOS : Joint Disorders & Orthopaedic Sports Medicine
|
August 23, 2022
Return to sport soccer after anterior cruciate ligament reconstruction: ISAKOS consensus
David Figueroa, Guillermo Arce, João Espregueira-Mendes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2017
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
S Tanadini-Lang, J Rieber, A R Filippi, et al.
Leukemia
|
May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
John M M Raemaekers, Marc P E André, Massimo Federico, et al.
The New England Journal of Medicine
|
December 25, 2015
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma
Michael Schaapveld, Berthe M P Aleman, Anna M van Eggermond, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 2, 2023
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
E Gkika, D Kostyszyn, T Fechter, et al.
Journal of the National Cancer Institute
|
December 22, 2020
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone de Vries, Michael Schaapveld, Cécile P M Janus, et al.
Page
of 139